Betterlife Pharma Inc (CSE:BETR)

0.0450 UNCHANGED

Streaming Delayed Price Updated: 12:19 PM EST, Dec 23, 2025 Add to My Watchlist

Price and Volume

Volume	678
Open	0.0450
Bid (Size)	0.0500 (50,000)
Ask (Size)	0.0600 (50,000)
Prev. Close	0.0450
Today's Range	0.0450 - 0.0450
52wk Range	0.0450 - 0.1750
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001

May 28, 2025

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Provides Comments on CEO’s Share Position Ownership and Recent BCSC Press Release

May 22, 2025

From BetterLife Pharma Inc.

Via GlobeNewswire

Performance

YTD	-59.1%	-59.1%
1 Month	-18.2%	-18.2%
3 Month	-47.1%	-47.1%
6 Month	-52.6%	-52.6%
1 Year	-57.1%	-57.1%

More News

BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders

May 14, 2025

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Announces Debt Settlements

May 06, 2025

From BetterLife Pharma Inc.

Via GlobeNewswire

Microcap Stocks to Watch: STSS, AGMH, FMTO, SUNE, Signal Strength Amid Market Volatility – More Picks Inside

April 10, 2025

Via AB Newswire

BetterLife Pharma Appoints Corporate Advisor

April 03, 2025

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Pharma Appoints New Director

March 31, 2025

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Announces Debt Conversions

March 10, 2025

From BetterLife Pharma Inc.

Via GlobeNewswire

USPTO Grants BetterLife’s BETR-001 Composition of Matter Patent

January 14, 2025

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Announces Favorable Outcome in New York Legal Claims

December 09, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Obtains Favourable Cardiac Safety Data for BETR-001

November 25, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Obtains Favourable Genotoxicity Data for Oral BETR-001

October 23, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Announces Fully Subscribed Private Placement Financing

August 29, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Highlights Advantages of Non-hallucinogenic LSD Derivative BETR-001 and Publication of its Methods to Treat Mood Disorders Patent

August 27, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Announces Closing of a Private Placement

July 02, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria

June 26, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Announces Closing of a Private Placement

June 14, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001

May 14, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Announces Intent to Complete Private Placement of Units

May 03, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Advances BETR-001 IND-enabling Studies

May 01, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

April 11, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001

April 03, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001

January 02, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University

March 04, 2024

From BetterLife Pharma Inc.

Via GlobeNewswire

BetterLife Announces Closing of a Private Placement

December 18, 2023

From BetterLife Pharma Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Betterlife Pharma Inc publicly traded?

Yes, Betterlife Pharma Inc is publicly traded.

What exchange does Betterlife Pharma Inc trade on?

Betterlife Pharma Inc trades on the Canadian Securities Exchange

What is the ticker symbol for Betterlife Pharma Inc?

The ticker symbol for Betterlife Pharma Inc is BETR on the Canadian Securities Exchange

What is the current price of Betterlife Pharma Inc?

The current price of Betterlife Pharma Inc is 0.0450

When was Betterlife Pharma Inc last traded?

The last trade of Betterlife Pharma Inc was at 12/23/25 12:19 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.